Peer AI is an AI-native platform focused on transforming regulatory submissions and documentation for life sciences and biopharma companies. It provides purpose-built, domain-specific AI agents and an intuitive, AI-powered user interface to automate and accelerate the drafting of complex regulatory documents such as clinical study reports (CSR), safety narratives, investigational new drug (IND) applications, biologics license applications (BLAs), protocols, investigator’s brochures (IBs), and plain language summaries, while keeping medical writers in full control at critical decision points.[1][5][8][15] The platform is positioned as an agentic AI solution for regulatory documentation, designed to reduce drafting time, provide workflow visibility and control across programs and teams, and offer predictive regulatory intelligence that helps teams anticipate reviewer queries and streamline submission workflows.[1][5][8][14][15] Peer AI’s mission is to transform drug development with AI-powered intelligence by connecting documentation, data, and decision-making so treatments can reach patients faster, drawing on deep expertise in life sciences, data protection and privacy, and generative AI.[3][14] The company serves pharmaceutical, biotech, and contract research organizations (CROs) worldwide and is backed by leading venture investors, having raised over $12 million in funding to expand its regulatory AI platform.[5][8][15]
